Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT)
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
3-2018
Journal Title
Biology of Blood and Marrow Transplantation
Department
Medicine
Second Department
Pediatrics
Third Department
Public Health
Recommended Citation
Perez, Y., Klejmont, L., Mahanti, H., Hochberg, J., Flower, A., Shi, Q., Moore, T. B., Talano, J., Shenoy, S., Morris, E., & Cairo, M. S. (2018). Elevated Pre-HSCT Ferritin is Not Associated with Increased Risk of Acute Graft Versus Host Disease in Patients with High Risk Sickle Cell Disease Undergoing Haploidentical T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT). Biology of Blood and Marrow Transplantation, 24 (3 Suppl.1), S205. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/360